Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Diane Scholl"'
1
A single center’s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation
Autor: Ying Huang, Leslie A. Andritsos, Bradley M. Haverkos, Sumithra Vasu, Lynn O'Donnell, Steve Devine, Samantha Jaglowski, Sam Penza, B Whittaker, Patrick Elder, Diane Scholl
Publikováno v: Bone marrow transplantation
In an otherwise eligible patient with relapsed lymphoma, inadequate mobilization of peripheral blood stem cells is a limiting factor to proceeding with an autologous hematopoietic cell transplantation (auto-HCT). Multiple strategies have been used to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72fa0039a6f5d4d2ee0bddd7f80d90d1
http://europepmc.org/articles/PMC5382040
Zobrazit plný text záznamu
2
An effective mobilization strategy for lymphoma patients after failed upfront mobilization with plerixafor
Autor: Ali McBride, Lynn O'Donnell, B Whittaker, Bradley M. Haverkos, Steven M. Devine, Sumithra Vasu, Leslie A. Andritsos, Diane Scholl, Sam Penza, Samantha Jaglowski
Publikováno v: Bone Marrow Transplantation. 49:1052-1055
In an otherwise eligible patient, inadequate mobilization of PBSCs is a limiting factor to proceeding with an auto-ASCT. In such situations, plerixafor is commonly added to improve PBSC collection yields along with cytokine (G-CSF alone) or chemomobi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc235948b7ff02ead42b21126231571f
https://doi.org/10.1038/bmt.2014.90
Zobrazit plný text záznamu
3
Barriers to Proceeding to Reduced-Intensity Allogeneic Stem Cell Transplant in Chronic Lymphocytic Leukemia
Autor: Nyla A. Heerema, Leslie A. Andritsos, Diane Scholl, John C. Byrd, Susan Geyer, Steven M. Devine, Samantha Jaglowski, Patrick Elder
Publikováno v: Journal of Leukemia.
To identify potential barriers to reduced-intensity conditioning (RIC) allogeneic stem cell transplantation (ASCT) in patients with chronic lymphocytic leukemia (CLL) we performed a retrospective review of patients referred for transplant consultatio
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b94c8e66696e07dba9f394cbed812939
https://doi.org/10.4172/2329-6917.1000121
Zobrazit plný text záznamu
5
Flavopiridol Is An Effective Therapy to Bridge Patients with Chronic Lymphocytic Leukemia (CLL) to Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant
Autor: Leslie A. Andritsos, Samantha Jaglowski, Jeffrey A. Jones, Joseph M. Flynn, John C. Byrd, Steven M. Devine, Michael R. Grever, Beth Fischer, Diane Scholl, Patrick Elder, Thomas S. Lin
Publikováno v: Blood. 116:2383-2383
Abstract 2383 Introduction: Allogeneic stem cell transplantation (SCT) is the only potentially curative therapy for patients with CLL. We reported that a major barrier to patients receiving SCT is an inability to attain the necessary disease control
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::422c2a2e411398893d1c9f7cb982b753
https://doi.org/10.1182/blood.v116.21.2383.2383
Zobrazit plný text záznamu
6
Conditioning with Fludarabine, Busulfan, and ATG Prior to Reduced-Intensity Allogeneic Stem Cell Transplant for CLL Is Associated with a Low Incidence of Acute Graft-Versus-Host Disease
Autor: Samantha Jaglowski, Leslie A. Andritsos, Diane Scholl, Steven M. Devine, Patrick Elder, John C. Byrd, Thomas S. Lin
Publikováno v: Blood. 116:4568-4568
Abstract 4568 Introduction: Allogeneic stem cell transplant (SCT) is the only potentially curative treatment available for CLL. While transplant-related mortality has decreased with use of reduced-intensity conditioning (RIC) regimens, acute and chro
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::089a667a3a3e4cc940060c59cbf9e5c2
https://doi.org/10.1182/blood.v116.21.4568.4568
Zobrazit plný text záznamu
7
Barriers to Reduced-Intensity Conditioning (RIC) Transplant in Patients with Chronic Lymphocytic Leukemia
Autor: Thomas S. Lin, Patrick Elder, Leslie A. Andritsos, John C. Byrd, Steven M. Devine, Samantha Jaglowski, Diane Scholl
Publikováno v: Blood. 114:1374-1374
Abstract 1374 Poster Board I-396 Introduction: Allogeneic stem cell transplantation is the only potentially curative therapeutic option for patients with CLL. However, in spite of recent improvements in transplant-related mortality due to the introdu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ed48b386b64e8b3697747bbdeccc1412
https://doi.org/10.1182/blood.v114.22.1374.1374
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje